Skip to main contentAI and Advanced
/
ASTERDM · NSEBSE SENSEX77,537.72+0.82%BSE |
NIFTY 5024,231.85+0.64%NSE |
NIFTY BANK57,495.9+0.45%NSE |
NIFTY IT30,673.05+0.79%NSE |
NIFTY AUTO29,301.75+0.40%NSE |
NIFTY FMCG47,863.25+0.82%NSE |
NIFTY PHARMA26,416+0.39%NSE |
NIFTY 50023,512.95+0.54%NSE |
AS
NSE · Equity shares · Healthcare Facilities-34.10 · -4.26%
Aster DM Healthcare ASTERDM
NSE:INR 765.9
BSE:INR 844.4
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for ASTERDM
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 800
Day rangeINR 756.05 — INR 798.35
52-week rangeINR 519.1 — INR 891.3
Volume98.84 L
Market cap44,157.18
P/E88.86
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)4,643.22
Net Income (INR Cr)388.14
Rev Growth (5 Year %)-11.61
EPS Growth (5 Year %)20.43
P/E Ratio88.86
Book Value82.9
EPS8
Price/BV9.24Computed
Research path: Interpret Aster DM Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
ASTERDMAster DM Healthcare1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 8,111.96 | 6,606.38 | 17,991.31 |
| Cash Equivalents | 1,325.36 | 47.07 | 77.6 |
| Other Liabilities Total | 119.01 | 100.3 | 288.83 |
| Long Term Debt | 558.44 | 483.71 | 446.08 |
| Common Stock Total | 518.13 | 499.52 | 499.52 |
| Other Current Assets Total | 64.03 | 25.35 | 13,622 |
| Total Assets | 8,111.96 | 6,606.38 | 17,991.31 |
| Current Portof LT Debt/Capital Leases | 172.39 | 163.58 | 140.07 |
| Total Equity | 4,575.86 | 3,428.07 | 4,559.79 |
| Long Term Investments | 1,301.42 | 254.56 | 13.74 |
| Retained Earnings(Accumulated Deficit) | 4,057.73 | -17.72 | 1,071.13 |
| Total Common Shares Outstanding | 51.69 | 49.82 | 49.78 |
| Tangible Book Valueper Share Common Eq | 82.9 | 62.9 | 85.67 |
| Goodwill Net | 264.12 | 264.12 | 264.12 |
| Total Liabilities | 3,536.1 | 3,178.31 | 13,431.52 |
| Total Debt | 2,219.66 | 2,017.77 | 1,383.75 |
| Short Term Investments | 160.01 | 1,196.5 | 23.8 |
| Cashand Short Term Investments | 1,485.37 | 1,361.09 | 106.03 |
| Total Receivables Net | 307.23 | 384.12 | 283.12 |
| Deferred Income Tax | 132.82 | 146.12 | 247.63 |
| Accounts Receivable-Trade Net | 307.23 | 326.97 | 264.64 |
| Property/Plant/Equipment Total-Net | 4,370.87 | 3,918.57 | 3,049.95 |
| Minority Interest | 257.84 | 223.38 | 470.32 |
| Total Current Liabilities | 979.16 | 879.21 | 11,288.26 |
| Total Inventory | 91.16 | 114.07 | 137.57 |
| Accounts Payable | 481.51 | 426.2 | 458.7 |
| Other Currentliabilities Total | 325.26 | 258.14 | 10,580.1 |
| Total Long Term Debt | 2,047.27 | 1,829.3 | 1,136.48 |
| Intangibles Net | 26.27 | 30.32 | 31.38 |
| Other Long Term Assets Total | 126.44 | 78.24 | 118.53 |
| Note Receivable-Long Term | 75.05 | 159.1 | 348.29 |
| Total Current Assets | 1,947.79 | 1,901.47 | 14,165.3 |
| Capital Lease Obligations | 1,488.83 | 1,345.59 | 690.4 |
| Accumulated Depreciation Total | Not available | -1,048.76 | -880.89 |
| Accrued Expenses | Not available | 6.4 | 2.19 |
| Other Equity Total | Not available | 375.33 | 777.7 |
| Prepaid Expenses | Not available | 16.84 | 16.58 |
| Additional Paid-In Capital | Not available | 2,230.61 | 2,222.41 |
| Cash | Not available | 117.52 | 4.63 |
| Treasury Stock-Common | Not available | -8.23 | -10.97 |
| Property/Plant/Equipment Total-Gross | Not available | 4,676.59 | 3,760.74 |
| Notes Payable/Short Term Debt | Not available | 24.89 | 107.2 |
| Unrealized Gain(Loss) | Not available | 348.56 | Not available |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio2.2
Price to Sale Ratio9.51
Growth
Debt 5Yr CAGR %-14.31
Margins
Operating Margin 12m13.01
Operating Margin 5y Avg9.83
Net Profit Margin 12m9.2
Net Profit Margin 5y6.72
Yield
Dividend Yield %0.36
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk27.44
Analyst consensus
ConsensusStrong Buy
Consensus score1.73
Analyst opinions11
Strong Sell count0
Sell count0
Hold count0
Buy count8
Strong Buy count3
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 65.06 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 73.09 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.26 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.55 | — |
| Global Health | INR 1,440.1 | 38,871.79 | 68.02 | — |
Shareholding
Ownership
- Promoter
- 53.72%
- FII
- 10.32%
- MF
- 15.93%
- Other
- 20.03%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Nigeria, Aster DM Healthcare Explore Healthcare Training, Mobile Clinic Partnership - TecheconomyMarket news · 20 Jul 2026, 7:27 pm
Nigeria, Aster DM Healthcare Explore Healthcare Training, Mobile Clinic Partnership Techeconomy
Boehringer Ingelheim and Aster DM Healthcare to improve medical education in UAE - BioSpectrum AsiaMarket news · 14 Jul 2026, 10:50 pm
Boehringer Ingelheim and Aster DM Healthcare to improve medical education in UAE BioSpectrum Asia
BCP Asia increases stake in Aster DM to 29.71% via amalgamation - scanx.tradeMarket news · 14 Jul 2026, 3:14 pm
BCP Asia increases stake in Aster DM to 29.71% via amalgamation scanx.trade
Movements. Aster DM Quality Care names Varun Khanna as MD and Group CEO - Medical BuyerMarket news · 7 Jul 2026, 8:05 am
Movements. Aster DM Quality Care names Varun Khanna as MD and Group CEO Medical Buyer
Aster DM, Quality Care merger completed; combined entity begins ops - The Times of IndiaMarket news · 6 Jul 2026, 7:37 pm
Aster DM, Quality Care merger completed; combined entity begins ops The Times of India
Varun Khanna Appointed Managing Director & Group CEO at Aster DM Quality Care - CXO DigitalpulseMarket news · 6 Jul 2026, 1:32 pm
Varun Khanna Appointed Managing Director & Group CEO at Aster DM Quality Care CXO Digitalpulse
Corporate actions
Events
- board MeetingsQuarterly Results
- board MeetingsAudited Results
- annual General MeetingPOM
- dividendRs.3.0000 per share(30%)Interim Dividend
- board MeetingsInterim Dividend
- annual General MeetingCOM
- board MeetingsQuarterly Results & ESOP
- board MeetingsQuarterly Results & ESOP
ShareKeyX Community
Discussion and sentiment for Aster DM Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Aster DM Healthcare Limited is an India-based healthcare service provider. The Company is operating in India with a presence across primary, secondary, tertiary, and quaternary healthcare through approximately 19 hospitals with 5,159 beds, 10 clinics, 203 pharmacies (Operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 262 labs and patient experience centers across five states in India. Its center of excellence includes Cardiac Sciences, Neurosciences, Gastro Sciences, Orthopaedics, Multi-Organ Transplant. Its pharmacy offers operating 203 pharmacies across southern India, delivering quality pharmaceutical, nutritional, infant care, lifestyle, and wellness products to communities and expanding healthcare access. Its labs deliver diagnostic services covering Biochemistry, Microbiology, Hematology, Clinical Pathology, Histopathology and Cytogenetics.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- ASTERDM
- BSE Code
- 540975
Questions
Stock FAQ
What is the symbol and ISIN of Aster DM Healthcare?
Aster DM Healthcare has the symbol ASTERDM and ISIN - INE914M01019.
What is the current price of Aster DM Healthcare?
Aster DM Healthcare is currently trading at INR 765.90.
What are the year high and year low of Aster DM Healthcare?
Aster DM Healthcare has a year high of INR 891.30 and a year low of INR 519.10.
What is the market capitalization of Aster DM Healthcare?
Aster DM Healthcare has a market capitalization of INR 44,157.18 crore.
What is the P/E ratio of Aster DM Healthcare?
Aster DM Healthcare has a P/E ratio of 88.86.
What is the dividend yield of Aster DM Healthcare?
Aster DM Healthcare has a dividend yield of 0.36%.
How is the financial performance of Aster DM Healthcare based on revenue, net income, and EPS?
Aster DM Healthcare has revenue of INR 4,643.22 crore, net income of INR 388.14 crore, and EPS of INR 7.90.
What is the book value of Aster DM Healthcare?
Aster DM Healthcare has a book value of INR 82.90.
What is the debt-to-equity ratio of Aster DM Healthcare?
Aster DM Healthcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Aster DM Healthcare?
Aster DM Healthcare has a price-to-book ratio of 9.24 and a price-to-sales ratio of 9.51.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.